Quantcast
Home > Quotes > PTIE
PTIE

Pain Therapeutics, Inc. Common Stock (PTIE) Quote & Summary Data

$1.095
*  
0.055
4.78%
Get PTIE Alerts
*Delayed - data as of Nov. 14, 2018  -  Find a broker to begin trading PTIE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 1.16 / $ 1.07
Share Volume
828,246
50 Day Avg. Daily Volume
2,686,185
Previous Close
$ 1.15
52 Week High / Low
$ 12.80 / $ 0.8098
Market Cap
18,855,134
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
2.23

Intraday Chart

Shares Traded

Share Volume:
828,246
50 Day Avg. Daily Volume:
2,686,185

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -1.17

Trading Range

The current last sale of $1.095 is 35.22% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.16 $ 12.80
 Low: $ 1.07 $ 0.8098

Company Description (as filed with the SEC)

Pain Therapeutics, Inc. develops proprietary drugs that offer significant improvements to patients and healthcare professionals. We generally focus our drug development efforts on disorders of the nervous system. Our expertise consists of developing new drug candidates and guiding these through various regulatory and development pathways in preparation for their eventual commercialization. By necessity, the conduct of drug development is complex, lengthy, expensive and risky. The FDA has not yet established the safety or efficacy of our drug candidates. 4 -------------------------------------------------------------------------------- Reverse Stock Split On May 4, 2017, following stockholder approval, our board of directors approved a reverse stock split at a ratio of 7-for-1.  ... More ...  

Nasdaq Official Price

Open Price:
$ 1.14
Open Date:
Nov. 14, 2018
Close Price:
$ 1.095
Close Date:
Nov. 14, 2018

Research Brokers before you trade

Want to trade FX?

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x